Creating supervised injection facilities in Toronto and Ottawa would be a cost-effective way to prevent people from developing hepatitis C, according to an updated analysis.
The researchers believe there is an 86 per cent chance one or more supervised injection facilities would be cost-effective in Toronto, and a 90 per cent chance in Ottawa.
They note these are conservative estimates as the team only considered facilities in freestanding buildings; incorporating the supervised site into existing health facilities could potentially reduce the costs. They considered new treatment options for hepatitis C, which are more effective, but also more expensive, than the treatments available when the analysis was first done in 2012.
Original research paper published in Addiction on November 30, 2015.
Names and affiliations of selected author
